Fellowship · Newark, DE
Sponsored by Christiana Care Health Services Inc
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events.
Journal for immunotherapy of cancer · 2021 · 762 citations · Gregory Masters
Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial.
Annals of oncology : official journal of the European Society for Medical Oncology · 2021 · 354 citations · Gregory Masters
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 264 citations · Gregory Masters
Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice.
The Journal of experimental medicine · 2021 · 249 citations · Gregory Masters
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 83 citations · Gregory Masters
Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study.
The Lancet. Haematology · 2023 · 84 citations · Jamal Misleh
High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 94 citations · Gregory Masters
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 117 citations · Gregory Masters